Vogt-Koyanagi-Harada disease in pregnancy : Case report and review of 32 patients in the literature
© 2024 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd..
Key Clinical Message: Systemic prednisolone including steroid pulse therapy would be safe in 32 pregnant women, who developed Vogt-Koyanagi-Harada disease in the literature. Prednisolone administration would be shortened by monitoring of serous retinal detachment with optical coherence tomography.
Abstract: A 30-year-old woman in 31 weeks of pregnancy with metamorphopsia and headache was diagnosed Vogt-Koyanagi-Harada disease. She underwent steroid pulse therapy and oral prednisolone 20 mg daily for 3 weeks until complete resolution of serous retinal detachment monitored by optical coherence tomography. Oral prednisolone was tapered and discontinued until uneventful delivery.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Clinical case reports - 12(2024), 3 vom: 07. März, Seite e8643 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Matsuo, Toshihiko [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case Reports |
|---|
| Anmerkungen: |
Date Revised 14.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1002/ccr3.8643 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369665538 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369665538 | ||
| 003 | DE-627 | ||
| 005 | 20240315000008.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240313s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ccr3.8643 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1329.xml |
| 035 | |a (DE-627)NLM369665538 | ||
| 035 | |a (NLM)38476834 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Matsuo, Toshihiko |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vogt-Koyanagi-Harada disease in pregnancy |b Case report and review of 32 patients in the literature |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 14.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. | ||
| 520 | |a Key Clinical Message: Systemic prednisolone including steroid pulse therapy would be safe in 32 pregnant women, who developed Vogt-Koyanagi-Harada disease in the literature. Prednisolone administration would be shortened by monitoring of serous retinal detachment with optical coherence tomography | ||
| 520 | |a Abstract: A 30-year-old woman in 31 weeks of pregnancy with metamorphopsia and headache was diagnosed Vogt-Koyanagi-Harada disease. She underwent steroid pulse therapy and oral prednisolone 20 mg daily for 3 weeks until complete resolution of serous retinal detachment monitored by optical coherence tomography. Oral prednisolone was tapered and discontinued until uneventful delivery | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Vogt‐Koyanagi‐Harada disease | |
| 650 | 4 | |a delivery | |
| 650 | 4 | |a optical coherence tomography | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a steroid pulse therapy | |
| 700 | 1 | |a Takahashi, Kasumi |e verfasserin |4 aut | |
| 700 | 1 | |a Kondo, Tsunemasa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical case reports |d 2013 |g 12(2024), 3 vom: 07. März, Seite e8643 |w (DE-627)NLM234405864 |x 2050-0904 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2024 |g number:3 |g day:07 |g month:03 |g pages:e8643 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ccr3.8643 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2024 |e 3 |b 07 |c 03 |h e8643 | ||